Literature DB >> 12794719

Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.

Elena Rodríguez-Iñigo1, Luisa Mariscal, Javier Bartolomé, Inmaculada Castillo, Cristina Navacerrada, Nuria Ortiz-Movilla, Margarita Pardo, Vicente Carreño.   

Abstract

Although occult hepatitis B virus (HBV) infection (HBV-DNA in serum in the absence of hepatitis B surface antigen [HBsAg]) is common in chronic hepatitis C, its characteristics are not well known. In this work, the presence of HBV-DNA (by polymerase chain reaction; PCR) and its distribution (by in situ hybridization) in liver biopsies and peripheral blood mononuclear cells (PBMCs) from 32 patients with chronic hepatitis C and occult HBV infection and in 20 HBsAg chronic carriers were determined. The results showed that serum HBV-DNA levels were statistically lower (P = 0.001) in patients with occult HBV infection than in HBsAg chronic carriers. The HBV infection pattern in liver cells was identical between patients with occult HBV infection and those with chronic hepatitis B. However, the mean percentage of HBV-infected hepatocytes was significantly lower (P = 0.001) in patients with occult HBV infection (5 +/- 4.44%) than in HBsAg chronic carriers (17.99 +/- 11.58%). All patients with chronic hepatitis B have HBV-DNA in their PBMCs while this occurred in 50% of the cases with occult HBV infection. In conclusion, patients with occult HBV infection have a low number of HBV-infected hepatocytes and this fact could explain the lack of HBsAg detection and low viremia levels found in these cases. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794719     DOI: 10.1002/jmv.10432

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.

Authors:  E Rodríguez-Iñigo; J Bartolomé; N Ortiz-Movilla; C Platero; J M López-Alcorocho; M Pardo; I Castillo; V Carreño
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

3.  Editorial Commentary: Another Call to Cure Hepatitis B.

Authors:  Ashwin Balagopal; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

Review 4.  Targeted DNA mutagenesis for the cure of chronic viral infections.

Authors:  Joshua T Schiffer; Martine Aubert; Nicholas D Weber; Esther Mintzer; Daniel Stone; Keith R Jerome
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

5.  Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.

Authors:  Sun Young Lee; Moon Seok Choi; Dongho Lee; Joon Hyoek Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 6.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

Review 7.  Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies.

Authors:  Katie Healy; Anna Pasetto; Michał J Sobkowiak; Chai Fen Soon; Markus Cornberg; Soo Aleman; Margaret Sällberg Chen
Journal:  Cells       Date:  2020-06-16       Impact factor: 6.600

Review 8.  Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection.

Authors:  Peiman Habibollahi; Saeid Safari; Nasser E Daryani; Seyed M Alavian
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

9.  Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach.

Authors:  Joshua T Schiffer; Dave A Swan; Daniel Stone; Keith R Jerome
Journal:  PLoS Comput Biol       Date:  2013-07-04       Impact factor: 4.475

10.  The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.

Authors:  Hui Wang; Meng Fang; Xing Gu; Qiang Ji; Dongdi Li; Shu-Qun Cheng; Feng Shen; Chun-Fang Gao
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.